Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond Publisher Pubmed



Pastaki Khoshbin A1, 2 ; Eskian M1, 3, 4 ; Keshavarzfathi M1, 2, 3, 5 ; Rezaei N3, 4, 6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Dr Qarib St, Keshavarz Blvd, Tehran, 14194, Iran
  4. 4. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  5. 5. Breast Cancer Association (BrCA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  6. 6. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Sheffield, United Kingdom

Source: Archivum Immunologiae et Therapiae Experimentalis Published:2019


Abstract

Metastasis is the direst face of cancer, and it is not a feature solely dependent on cancer cells; however, a complex interaction between cancer cells and host causes this process. Investigating the mechanisms of metastasis can lead to its control. Myeloid-derived suppressor cells (MDSCs) are key components of tumor microenvironment that favor cancer progression. These cells result from altered myelopoiesis in response to the presence of tumor. The most recognized function of MDSCs is suppressing anti-tumor immune responses. Strikingly, these cells are among important players in cancer dissemination and metastasis. They can exert their effect on metastatic process by affecting anti-cancer immunity, epithelial–mesenchymal transition, cancer stem cell formation, angiogenesis, establishing premetastatic niche, and supporting cancer cell survival and growth in metastatic sites. In this article, we review and discuss the mechanisms by which MDSCs contribute to cancer metastasis. © 2018, L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.
Related Docs
View other Related Docs
1. Tumor Immunology, Clinical Immunology (2022)
2. The Immunobiology of Myeloid-Derived Suppressor Cells in Cancer, Tumor Biology (2016)
3. The Role of Myeloid-Derived Suppressor Cells in Lung Cancer and Targeted Immunotherapies, Expert Review of Anticancer Therapy (2022)
4. The Pro-Tumorigenic Responses in Metastatic Niches: An Immunological Perspective, Clinical and Translational Oncology (2023)
5. The Roles of Metabolic Profiles and Intracellular Signaling Pathways of Tumor Microenvironment Cells in Angiogenesis of Solid Tumors, Cell Communication and Signaling (2022)
6. Pro-Tumorigenic Functions of Macrophages at the Primary, Invasive and Metastatic Tumor Site, Cancer Immunology# Immunotherapy (2020)
7. Myeloid-Derived Suppressor Cells in Gastrointestinal Cancers: A Systematic Review, Journal of Gastroenterology and Hepatology (Australia) (2016)
8. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (12)
Seyed Hamidollah Ghaffari (3)
Other Related Docs
9. Recruited Bone Marrow Derived Cells, Local Stromal Cells and Il-17 at the Front Line of Resistance Development to Anti-Vegf Targeted Therapies, Life Sciences (2019)
10. Immune Regulatory Network in Successful Pregnancy and Reproductive Failures, Biomedicine and Pharmacotherapy (2017)
11. Tumor-Associated Macrophages: Role in Cancer Development and Therapeutic Implications, Cellular Oncology (2019)
12. Fusobacterium Nucleatum and Colorectal Cancer: A Mechanistic Overview, Journal of Cellular Physiology (2019)
13. Immune Landscape of Hepatocellular Carcinoma: From Dysregulation of the Immune Responses to the Potential Immunotherapies, Cell Biochemistry and Function (2024)
14. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)
15. Resistance to Immunotherapy in Human Malignancies: Mechanisms, Research Progresses, Challenges, and Opportunities, Journal of Cellular Physiology (2022)
16. Lung Cancer-Associated Brain Metastasis: Molecular Mechanisms and Therapeutic Options, Cellular Oncology (2017)
17. Targeting Hypoxia and Hypoxia-Inducible Factor-1 in the Tumor Microenvironment for Optimal Cancer Immunotherapy, Journal of Cellular Physiology (2022)
18. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
19. Expression of Recombinant G-Csf Receptor Domains and Their Inhibitory Role on G-Csf Function, Research in Pharmaceutical Sciences (2020)
20. Evaluation of the Anti-Tumor Effects of an Anti-Human Epidermal Growth Factor Receptor 2 (Her2) Monoclonal Antibody in Combination With Cd11b+/Gr-1+ Myeloid Cells Depletion Using a Recombinant Peptibody in 4 T1-Her2 Tumor Model, International Immunopharmacology (2023)
21. State of the Art in Immunotherapy of Neuroblastoma, Immunotherapy (2019)
22. Targeting Macrophage-Mediated Tumor Cell Phagocytosis: An Overview of Phagocytosis Checkpoints Blockade, Nanomedicine Intervention, and Engineered Car-Macrophage Therapy, International Immunopharmacology (2022)
23. Macrophage’S Role in Solid Tumors: Two Edges of a Sword, Cancer Cell International (2023)
24. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
25. Chemotherapy: A Double-Edged Sword in Cancer Treatment, Cancer Immunology# Immunotherapy (2022)
26. Stat3 Targeting by Polyphenols: Novel Therapeutic Strategy for Melanoma, BioFactors (2017)
27. How Micrornas Affect the Pd-L1 and Its Synthetic Pathway in Cancer, International Immunopharmacology (2020)
28. Recent Progress in Cancer Immunotherapy: Overview of Current Status and Challenges, Pathology Research and Practice (2023)
29. Microfluidics for Detection of Exosomes and Micrornas in Cancer: State of the Art, Molecular Therapy Nucleic Acids (2022)
30. Identification and in Vitro Characterization of Novel Nanobodies Against Human Granulocyte Colony-Stimulating Factor Receptor to Provide Inhibition of G-Csf Function, Biomedicine and Pharmacotherapy (2017)
31. The Multifaceted Role of Extracellular Vesicles (Evs) in Colorectal Cancer: Metastasis, Immune Suppression, Therapy Resistance, and Autophagy Crosstalk, Journal of Translational Medicine (2024)
32. Suppressive Effects of Low-Dose 5-Fluorouracil, Busulfan or Treosulfan on the Expansion of Circulatory Neutrophils and Myeloid Derived Immunosuppressor Cells in Tumor-Bearing Mice, International Immunopharmacology (2016)
33. Engineering an Anti-Granulocyte Colony Stimulating Factor Receptor Nanobody for Improved Affinity, Life Sciences (2020)
34. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
35. Minimal Information for Studies of Extracellular Vesicles (Misev2023): From Basic to Advanced Approaches, Journal of Extracellular Vesicles (2024)
36. Targeting Cd84 Protein on Myeloid-Derived Suppressor Cells As a Novel Immunotherapy in Solid Tumors, Computer Methods and Programs in Biomedicine (2025)
37. The Molecular Signature of Breast Cancer Metastasis to Bone, Anti-Cancer Drugs (2016)
38. Fuzzy Stochastic Petri Net With Uncertain Kinetic Parameters for Modeling Tumor-Immune System, 2018 25th Iranian Conference on Biomedical Engineering and 2018 3rd International Iranian Conference on Biomedical Engineering# ICBME 2018 (2018)
39. Myeloid-Derived Suppressor Cells in B Cell Malignancies, Tumor Biology (2015)
40. Breast Tumor Metastasis Following Filgrastim Administration Due to the Sdf-1/Cxcr4 Pathway, Medical Oncology (2023)